Site-selective installation of BASHY fluorescent dyes to Annexin V for targeted detection of apoptotic cells by Cal, PMSD et al.
368 | Chem. Commun., 2017, 53, 368--371 This journal is©The Royal Society of Chemistry 2017
Cite this:Chem. Commun., 2017,
53, 368
Site-selective installation of BASHY fluorescent
dyes to Annexin V for targeted detection of
apoptotic cells†
Pedro M. S. D. Cal,ab Florian Sieglitz,a Fa´bio M. F. Santos,c Ca´tia Parente Carvalho,d
Ana Guerreiro,a Jean B. Bertoldo,b Uwe Pischel,d Pedro M. P. Gois*c and
Gonçalo J. L. Bernardes*ab
Fluorophores are indispensable for imaging biological processes.
We report the design and synthesis of azide-tagged boronic acid
salicylidenehydrazone (BASHY) dyes and their use for site-selective
labelling of Annexin V. The Annexin V-BASHY conjugate maintained
function and fluorescence as demonstrated by the targeted detection
of apoptotic cells.
Molecular imaging is a life sciences multidiscipline that reflects
the analysis of biological processes in living systems at a cellular
and molecular level.1–4 Of the current methods available, optical
imaging is perhaps the most relevant because of its high-
sensitivity, the use of non-radioactive components, low cost
and easy access.5–8 Therefore, it is not surprising that the past
two decades have witnessed the disclosure of a large number of
optical imaging probes aimed at evaluating the expression and
activity of specific molecules or biological processes.9,10 Further-
more, the conjugation of optical imaging probes with disease-
specific ligands such as antibodies enables the targeted imaging
of particular tissues which is of key relevance, for example, in
cancer diagnosis.11 While probes with optimal fluorescence
properties are often reported, the design of probes equipped
with suitable handles that can be directly used in site-selective
protein modification approaches is less common. This is of key
importance since probe conjugation can often result in fluores-
cence quenching or loss of protein function.
Very recently we reported the synthesis of a new family of
photostable fluorescent dyes featuring a tridentate structure
obtained by the modular assembly of structurally diverse
boronic acids with modular Schiﬀ base ligands.12 This unique
family of boronic acid salicylidenehydrazone (BASHY) dyes
show a polarity-dependent emission in the green-to-yellow
spectral range, quantum yields as high as 0.6 in non-polar
solvents, and a remarkable brightness similar to other widely
used archetypal fluorophores such as rhodamines or cyanine
dyes.13 Additionally, BASHY dyes also exhibit a highly modular
structure that can be easily tuned for diﬀerent applications.
Herein we show that the BASHY fluorescent core can be
eﬃciently modified in order to incorporate a ‘‘clickable’’ handle
to site-selectively functionalize a protein probe without com-
promising either the dye’s fluorescent properties or the protein
function (Fig. 1).
Annexin V is a protein used as an early marker of apoptosis
by binding to a phospholipid membrane component, phosphatidyl
serine (PS), which is translocated from the inner to the outer leaflet
of the plasma membrane during apoptosis.14–16 Heterogeneous
mixtures of fluorescently labelled Annexin V are often part of
commercially available kits for detection of apoptosis. The
multiple, non-site-specific incorporation of fluorescence dyes
into protein biomarkers can however lead to a significant
reduction in binding ability. Instead, we envisioned a two-step
strategy that would allow for precise installation of a BASHY
fluorescent probe at a pre-determined site within the amino acid
sequence of a biomarker, in this case Annexin V, through strain-
promoted azide–alkyne cycloaddition (SPAAC).17–20 Such a strategy
would find broad utility not only for Annexin V but also for
Fig. 1 Proposed site-selective modification of protein biomarkers using
BASHY fluorescent dyes.
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other more sensitive protein systems where random labelling
may destroy completely protein specific activity.
Considering the simple and robust synthetic route based on
the modular assembly of boronic acids with Schiﬀ-base ligands,
we thought to introduce a reactive azide handle that is compatible
with azide–alkyne bioorthogonal ligation reactions. Shortly, dye 3,
featuring a carboxylic acid function, was readily prepared from
Schiff-base 1 in 97% isolated yield. This complex smoothly under-
went TBTU mediated amidation with 2-azidoethylamine to afford
compound 4 in excellent yields (Fig. 2a). Importantly, the acid (3)
or azide (4)-tagged BASHY dyes retained the photophysical proper-
ties of the reported BASHY dye,12 including high quantum yields,
narrow absorption and emission bands, and high molar absorp-
tion coefficients (Fig. 2b and Tables S1, S2, Fig. S1–S3, ESI†).
Furthermore, we studied the stability and cytotoxicity of the
BASHY probe 4. Importantly, 4 did not react with ethyleneglycol
which is potentially reactive towards boronic acids (Fig. S4, ESI†)
and no toxic effects were observed in two different cell lines
(Fig. S5, ESI†).
With the azide-tagged BASHY dye 4 in hand, we decided to
test its reactivity under SPAAC conditions21 using Annexin V
as a model biomarker. In a first step, it was required to install
the strained-alkyne counterpart on a precise site within the
sequence of the protein. Annexin V displays a free, hindered
cysteine (Cys) at position 316, which has been shown to be
reactive using a variety of diﬀerent alkylating and Michael-
acceptor reagents including maleimides.22–24 Using commercially
available dibenzocyclooctyne-maleimide (mal-DBCO, 5) that con-
tains a reactive maleimide at one end and a strained-cyclooctyne
ring at the other end, we tested a number of conditions for
the reaction of 5 with Annexin V. We found that complete
conversion could be achieved when using 25 equivalents of 5 in
aqueous buffered solution (TrisHCl, 20 mM. pH 8) for 5 days at
room temperature (Fig. 3 and Table S3, Fig. S6 and S7, ESI†).
After purification using size-exclusion chromatography, a single
protein product corresponding to the mass of DBCO-tagged
Annexin V was detected using liquid-chromatography mass-
spectrometry (LC-MS) analysis (Fig. 3). Upon tryptic digest and
analysis using LC-MS/MS, we confirmed that Cys316 is the
primary site of modification (Fig. S8, ESI†).
With the strained-alkyne moiety site-selectively installed at
Cys 316 of Annexin V, we next tested the labelling SPAAC reaction
using the azide-BASHY fluorescent dye 4. Labelling proceeded
smoothly in sodium phosphate buﬀer (NaPi, 50 mM, pH 6) and
completion was achieved after 6 hours at room temperature
(Fig. 3). Gratifyingly, and after purification, a homogenous
Annexin V-BASHY construct was identified by LC-MS analysis
(Fig. 3 and Fig. S9, ESI†). The secondary structure protein
content of the conjugates Annexin V-mal-DBCO and Annexin
V-BASHY was analysed by circular dichroism (Fig. S10, ESI†),
showing no significant diﬀerences from unmodified Annexin V.
In order to have a basis of comparison, a commercially available
azide dye (sulfo-cyanine5 azide – Cy5-N3) was used to label Annexin
V under identical SPAAC conditions. This near-infrared (NIR) optical
probe was chosen as a reference because it is routinely used in
biological imaging including apoptosis when conjugated to
Annexin V.2,25–27 The site-selectively modified Annexin V-Cy5
was used as a specific positive control, since Annexin V is usually
labelled in a non-selective manner through lysine (Lys) bioconjuga-
tion using this dye.We have also prepared an heterogeneous Annexin
V conjugate using an NHS-ester activated fluorescein isothiocyanate
isomer I (NHS-FITC).16 Both conjugates were purified to afford
two fluorescent conjugates, the homogenous Annexin V-Cy5 and
heterogeneous Annexin V-FITC (see Fig. S11 and S12, ESI†).
The three synthesised and purified conjugates were assessed
for their potential to targeted imaging of apoptotic cells using
Fig. 2 (a) One pot-assembly of boronic acid-based heterocycle function-
alized with a bioorthogonal handle. (b) Normalized UV/Vis absorption (black)
and fluorescence (red) spectra of dye 4 in 5%DMSO/NaPi (50 mM, pH 6).
TBTU, O-(benzotriazol-1-yl)-N,N,N0,N0-tetramethyluronium tetrafluoro-
borate; DMF, N,N-dimethylformamide.
Fig. 3 Reaction of Annexin V (5.0 mM) with 25 equivalents of mal-DBCO 5
in TrisHCl buﬀer (20 mM, pH 8) and 10% DMF, during five days at room
temperature. Reaction of purified Annexin V-mal-DBCOwith 5 equivalents
of BASHY dye 4 in NaPi buﬀer (50 mM, pH 6) and 10% DMF during 6 hours
at room temperature. Alongside of each conjugate the deconvoluted mass
spectrum is shown recording the masses for each construct.
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confocal microscopy.2 For this purpose, we used actinomycin D
as an apoptosis inducer and DMSO as the negative control.16
HeLa cells were incubated with either actinomycin D or DMSO
(control) for 6 hours followed by incubation with Annexin
V-BASHY for 20 minutes. Finally, cells were fixed and the nuclei
stained with Hoechst 33342 (Fig. 4). The specificity for PS
binding of the homogenous Annexin V-Cy5 dye conjugate and
the heterogenous Annexin V-FITC were also analysed using the
same protocol in separate trials (see Fig. S13–S20). Gratifyingly,
the Annexin V-BASHY conjugate was successfully able to target
apoptotic cells with similar efficiency as both control constructs
(Fig. 4). Moreover, in a blocking experiment where cells were
incubated with non-fluorescent Annexin V-mal-DBCO before
addition of Annexin V-BASHY, we observed a significant
decrease in fluorescence which demonstrates the specificity
of the BASHY-tagged biomarker (Fig. S15, ESI†). These data
demonstrate the utility of BASHY-protein conjugates built
using site-selective protein labelling approaches for bioimaging
due to their stability and non-detectable quenching or photo-
bleaching. These properties lead to low levels of unselective fluores-
cence background and high signal-to-noise ratio, as demonstrated
for the detection of apoptotic cells through confocal microscopy
(Fig. S13–S20, ESI†).
In this communication, we report for the first time the
structural modification of BASHY fluorescent dyes specifically
designed for the site-selective labelling of a protein biomarker.
The BASHY core was simply modified with an azide-tag without
altering the core photophysical properties and was then used in
a two-step protocol that enabled the precise installation of the
fluorescent dye at position 316 of the apoptosis biomarker
Annexin V. Importantly, the fluorescence of BASHY was
retained after protein labelling and the conjugate successfully
targeted and detected apoptotic cells maintaining high levels of
specific activity. Our strategy uses a synthetically accessible core
that permits the facile introduction of ‘‘clickable’’ handles for
subsequent precise protein fluorescent labelling. This strategy
that has been successfully demonstrated for the labelling of
Annexin V and detection of apoptotic cells may find broader
utility when applied to protein biomarkers that are sensitive
and loose their activity when randomly conjugated. Additionally,
and as a future application, the reported combined synthesis and
protein site-selective labelling using BASHY dyes, can be particularly
useful for multimodality imaging applications,28–30 since the
BASHY core can act itself as an optimal imaging agent while
allowing attachment of probes used in other imaging modalities
(e.g., magnetic resonance imaging (MRI), single photon emission
computed tomography (SPECT) or positron emission tomo-
graphy (PET)).
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